Fidelity Investments
RVLP

Fidelity Investments’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Fidelity Investments’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$43 – 5755
2023
Q3 		$43 Buy
+500
New +$144 ﹤0.01% 4961

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Fidelity Investments's RVLP Position: Q4 2023 in Review

Fidelity Investments sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 500 shares — an estimated $43 sold.

Fidelity Investments first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $43 in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Fidelity Investments reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 500 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $43.
  • Fidelity Investments first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • Fidelity Investments's RVL Pharmaceuticals plc Ordinary Shares position peaked at $43 in Q3 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.